Batch documentation available to approved accounts
Immune
Thymosin Alpha-1
Naturally occurring thymus-derived peptide positioned for immune modulation, T-cell maturation, natural killer cell activity, cytokine balancing, long-COVID, chronic-viral, and immune-aging research. Mechanism: Enhances T-cell maturation, stimulates natural killer cells, and modulates cytokines bidirectionally — enhancing where underactive and calming where overactive.
Research context
Long COVID immune dysregulation; chronic viral infections; immune deficiency states; integrative oncology support; aging immune function/thymic involution.
Material information
- Grade
- Research Use Only (RUO)
- Format
- Lyophilized peptide material
- Purity
- Greater than 99%
- Appearance
- Lyophilized powder
Documentation
Batch-specific documentation may be available for approved account review. View documentation standards.
Regulatory status
For laboratory research use only. Not for human consumption, diagnosis, treatment, cure, or prevention of disease.
Restrictions
Research use only
This material is offered for research use only. Not for human or animal use. Not intended for clinical, diagnostic, therapeutic, veterinary, or personal use. PeptaPharma does not provide dosing, administration, or treatment guidance.
Synthesized & tested in the United States.
PeptaPharma materials are produced and analytically tested in U.S. facilities. Batch-level documentation and Certificates of Analysis accompany each lot for approved-account review.